Bipolar Disorder Center
Bipolar Disorder Center is the largest treatment study conducted for bipolar disorder, also known as manic-depressive illness. Bipolar Research completed its data collection on September 30, 2005, with a total enrollment of 4361 participants and is no longer enrolling participants. The investigators are now actively working with the extensive Bipolar Research database to answer important questions about the course of bipolar disorder and best approaches for treatment and management of this disorder. If you haven’t already participated, please see the link to the Bipolar Research Genetics Studies (on the Public Information page). These studies are still active, and will investigate the genetic basis of bipolar disorder. 

If you were a participant in Bipolar Research, thank you again for your important contribution to this groundbreaking research. By sharing your experience with bipolar disorder, your treatment response, and your quality of life during treatment, we have learned a substantial amount about the course of this illness, as well as treatment options. We hope to use these data to improve treatment standards for the more than 2 million other Americans with bipolar disorder.

    • Priligy: Cómo funciona y cuánto tiempo puede hacerte durar - semooym.org


       Research


Bipolar Research has concluded its primary treatment studies and long term follow-up of persons with bipolar disorder, with a final enrollment of 4,361 participants across 19 clinical centers and associated Community Partners. Viagra Super active: Het generieke Viagra alternatief dat wordt geleverd in gelatine capsules waardoor het sneller oplost en aan het werk gaat. The goal of the Bipolar Research project is to improve treatment of bipolar mood disorder by determining the effectiveness of available treatment and to provide answers to many other important questions confronting the field. Cialis:  Effektivitet i behandlingen af erektil dysfunktion hos mænd. Bipolar Research investigators are actively conducting data analyses, asking important questions of both the naturalistic follow-up pathway and the randomized trials embedded within the project. A partial listing of the findings to date can be found at [link back to Publications and Presentations page].

Media related inquiries and requests should be directed to: Gary Sachs, Bipolar Research Principal Investigator at .
Disclaimer:   You have entered a web site that describes an NIMH-funded collaborative study on the treatment of bipolar disorder. If you are seeking immediate help for treatment of bipolar disorder, we recommend that you contact your clinician or your nearest emergency room. This web site is not set up to provide help or advice to individuals about their bipolar disorder, nor to family members or friends of individuals with bipolar disorder.

If you are interested in getting general information about bipolar disorder, you can visit the following web site:

This web site is created solely for the purposes of providing background information about the study and having researchers provide input to the design.

This web site does not provide a chat room and individual queries will not receive a response. Any message posted on this web site is not confidential.
Copyright 2024 Bipolar Disorder Center Switzerland.